Navolab develops functionally informed immune diagnostics that address pre‑treatment therapy response heterogeneity in inflammatory diseases.
The platform translates functional immune cell activity into decision‑relevant insight to support therapy response prediction, clinical development, and regulatory strategy.
By adding a functional layer beyond static biomarkers, Navolab helps navigate uncertainty in therapy selection and development across immunology programs.
By integrating functional immune readouts into development and clinical workflows, the platform helps reduce uncertainty around therapy response where static biomarkers alone are insufficient.

Navolab Diagnostics

Org chart

Teams

Offices